search icon
      blog search icon

      Ault Global Holdings, Inc. (DPW) stock price is inclining but why this happened? - Stocks Telegraph

      By Mahrukh Rehan

      Published on

      September 8, 2021

      9:17 AM UTC

      Ault Global Holdings, Inc. (DPW) stock price is inclining but why this happened? - Stocks Telegraph

      DPW stock price inclined to $2.8 with an increase of 4.87% in the premarket. However, the last trading session concluded at $2.67 with an incline of 0.38%.

      What’s happening?

      No latest news on DPW stock has been observed for today. Yet there is some current news that will be covered in this post. Let’s dig deep into it.

      DPW Regains Compliance with NYSE American Continued Listing Standards

      On 17th August 2021, DPW reported that AGH has achieved compliance with all continuing listing criteria set out in Section 704 of the NYSE American Company Guide, according to a letter from the NYSE American LLC.

      AGH has resolved its continued listing deficiency by meeting the continued listing requirements, and the “BC” designation, which denotes noncompliance with the NYSE American’s listing standards.

      DPW announces second-quarter financial results 2021

      DPW announces second-quarter financial results 2021 on 16th August 2021. Revenue was $75.4 million, 585 percent more than the previous six-month period’s; while the Company began cryptocurrency mining activities with about 1,000 miners, generating revenue of $421,000; and

      In the previous six months, the company had a net loss of $7.9 million, resulting in a net income of $44.2 million.

      Additional Investment in Alzamend announced by DPW

      It was stated by DPW on 4th August 2021 that Digital Power Lending, LLC (“DPL”), a wholly-owned subsidiary of Alzamend Neuro, Inc., a related party, and early clinical-stage biopharmaceutical company focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders,  which required additional investment in Alzamend Neuro, Inc.

      The US Food and Drug Administration issued Alzamend a “study may proceed” letter on July 28, 2021, for a Phase 1a study under Alzamend’s Investigational New Drug application for AL001, a lithium-based ionic cocrystal oral therapy for patients with dementia-related to mild, moderate, and severe cognitive impairment associated with Alzheimer’s disease.

      Based on the achievement of this milestone, Alzamend sold an additional 1,333,333 shares of its common stock to DPL for $2 million and issued warrants to DPL to acquire 666,667 shares of Alzamend common stock. The goal of this investment in Alzamend was to provide the company with a committed source of cash based on milestones to support Alzamend’s therapeutic treatments until Phase 1 clinical trials were completed.

      Formation of Ault Global Real Estate Equities

      On July 16, 2021, DPW announced the formation of Ault Global Real Estate Equities, Inc., a Nevada corporation, to invest in commercial real estate in the United States, with a focus on the middle-market category. To drive this approach, AGREE has named Christopher K. Wu as its Chief Executive Officer.

      Conclusion

      In comparison to the same period last year, the second-quarter performance of DPW stock is remarkable. In terms of sales and operations, the stock is improving. Lending and trade operations have experienced tremendous development. The DPW stock has a robust balance sheet. In a nutshell, long-term investors may find this stock to be an excellent investment.

      More From Stocks telegraph